Nano-X Imaging Ltd. (NNOX)
After hours:
- GlobeNewswire
USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission
Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its wholly-owned subsidiary, USARAD Holdings, Inc., a leading provider of teleradiology services, has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation for the sixth time by demonstrating con
- GlobeNewswire
Nanox to Participate in Three Upcoming Investor Conferences in May 2024
PETACH TIKVA, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will participate in three investor conferences in the month of May 2024: EF Hutton 2024 Annual Global ConferenceAGP 2024 Healthcare ConferenceBenchmark 2024 Healthcare House Call Virtual Conference About EF Hutton 2024 Annual Global Conference Nanox’s Chief Executive Officer, Erez Meltzer, and
- GlobeNewswire
Nanox Files 2023 Annual Report on Form 20-F
PETACH TIKVA, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (“SEC”) on April 22, 2024. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at ht
